Psyched Wellness Announces Closing of Private Placement and Shares for Debt Transaction and Resignation of a Director
Concerned Shareholder of LevelJump Healthcare Corp. Requisitions Shareholder Meeting to Address Necessary Leadership Changes
Psyched Wellness Announces Positive Toxicology Assessment and Provides Path to Market for a Legal Psychedelic Mushroom Product
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
